# Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients

> **NCT03640468** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 36 (estimated)

## Conditions studied

- Septic Shock
- Anesthesia

## Interventions

- **DRUG:** Ketamine full dose
- **DRUG:** Ketamine half dose
- **DRUG:** Lidocaine
- **DRUG:** Midazolam
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03640468
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-20
- **Primary completion:** 2019-06-15
- **Final completion:** 2019-07-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640468, "Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03640468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*